Review



cd33 rabbit polyclonal antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Bioss cd33 rabbit polyclonal antibody
    Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) <t>CD33</t> + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.
    Cd33 Rabbit Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd33 rabbit polyclonal antibody/product/Bioss
    Average 93 stars, based on 3 article reviews
    cd33 rabbit polyclonal antibody - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration"

    Article Title: ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration

    Journal: Frontiers in Molecular Biosciences

    doi: 10.3389/fmolb.2023.1202524

    Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) CD33 + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.
    Figure Legend Snippet: Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) CD33 + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.

    Techniques Used: Expressing



    Similar Products

    cd33 rabbit polyclonal antibody  (Bioss)
    93
    Bioss cd33 rabbit polyclonal antibody
    Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) <t>CD33</t> + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.
    Cd33 Rabbit Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd33 rabbit polyclonal antibody/product/Bioss
    Average 93 stars, based on 1 article reviews
    cd33 rabbit polyclonal antibody - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) CD33 + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Frontiers in Molecular Biosciences

    Article Title: ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration

    doi: 10.3389/fmolb.2023.1202524

    Figure Lengend Snippet: Relationship between CD8 + T cell and MDSCs and the expression of ARPC1B. (A–B) CD8 + T-cell expression was observed in KIRC and normal renal tissues (arrow indicates the clustering of CD8 + T cells). (C) Correlation between the number of CD8 + T cells and the expression of ARPC1B in KIRC. (D) Differences in the number of CD8 + T cells between KIRC and normal tissues. (E–F) CD33 + MDSCs expression observed in KIRC and normal renal tissue (arrow indicates the clustering of CD33 + MDSCs). (G) Correlation between the number of CD33 + MDSCs and the expression of ARPC1B in KIRC. (H) Differences in the number of CD33 + MDSCs between KIRC and normal tissues. (I) Correlation between the number of CD8 + T cells and number of CD33 + MDSCs in KIRC. NS (not significant with a p -value greater than 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: Subsequently, endogenous peroxidase was blocked with 3% hydrogen peroxide for 10 min. Then, the FFPE sections were incubated with ARPC1B rabbit polyclonal antibody (1:500, Bioss Biotechnology, China), CD8 monoclonal antibody (working solution, Agilent Dako, Denmark), and CD33 rabbit polyclonal antibody (1:400, Bioss Biotechnology, China), followed by incubation with HRP secondary antibody, and finally stained with peroxidase/DAB immunohistochemistry.

    Techniques: Expressing